Perioperative factors associated with differences in adjusted hospitalization costs; all displayed factors are significantly associated with increased or decreased adjusted costs. by Saad Mallick (17283479)

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. by Melinda H. Spooner (6551933)

“…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …”

Table indicating whether a risk factor showed a significant association with complicated grief for any time point in the study. by Emma A. M. Sanderson (12225310)

Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points. by Jessie B. Moore (12578140)

Subjects:

Comparison of Alzheimer’s disease pathology in the hippocampus between the CCH and control groups. by Jung-In Lee (1731727)

Subjects:

Pro- and anti-inflammatory cytokines are significantly decreased at acute time points following IR. by Jordan A. Gunning (18143970)

Diseases excluded from the analysis. by Rieko Kondo (10010647)

Subjects:

Decrease in cell movement as revealed by IPA. by Afrooz Jahedi (14636554)

Subjects:

Levels of initial albumin, prealbumin, and ischemia-modified albumin based on disease diagnosis and new-onset disease. by Sung Soo Ahn (9033695)

Subjects:

Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

Subjects:

Number of developmental-associated genes in Landrace and Tongcheng pigs at each time point. by Yalan Yang (735975)

Summary statistics from significant disease associations. by Margaret Sunitha Selvaraj (13994016)

Subjects:

Significance of the association of infectious diseases with EBF and other associated factors. by Faruq Abdulla (8061062)

“…<p>Significance of the association of infectious diseases with EBF and other associated factors.…”

Factors associated with exacerbations. by Rieko Kondo (10010647)

Subjects:

Some of the significant disease-pathways associated with COVID-19. by Mahnaz Habibi (11204536)

Metformin/rifampicin combination decreases <i>S</i>. <i>aureus</i> load and persisters in Mice. by Xiao-Qi Lin (9548375)

Subjects:

Significant disease phenotypes with LADA loci. by Margaret Sunitha Selvaraj (13994016)

Subjects:

Change in the levels of parental stressors or rewards between time point 1 and time point 2. by Ragnhild Bjørknes (4908577)

Subjects:

Networks of affect states: Significant paths. by Anna Kuranova (8460411)

“…Dashed red edges represent negative connections, meaning that the decrease in one node variable at time point t-1 is associated with decrease in the other variable at time t. …”

Shows 48/86 genes have differential expression consistent with the direction of decrease in cell movement. by Afrooz Jahedi (14636554)

Subjects: